Tags

Type your tag names separated by a space and hit enter

A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
Fertil Steril. 2010 Feb; 93(2):360-3.FS

Abstract

OBJECTIVE

To compare stimulation profiles, pregnancy, and live birth rates in poor responders during in vitro fertilization (IVF) cycles using either a gonadotropin-releasing hormone (GnRH) antagonist (cetrorelix) or a GnRH agonist flare protocol (leuprolide).

DESIGN

Retrospective chart review.

SETTING

A university-affiliated IVF program.

PATIENT(S)

Women designated as poor responders based on a prior stimulation cycle or baseline follicle-stimulating hormone (FSH) level of >10 mIU/mL, who needed at least 375 IU of starting daily gonadotropins in the study cycle.

INTERVENTION(S)

Administration of GnRH agonist flare or GnRH antagonist protocol.

MAIN OUTCOME MEASURE(S)

Clinical pregnancy rate, live birth rate.

RESULT(S)

For 68 GnRH antagonist and 45 GnRH agonist flare cycles, the groups were similar with respect to age (38.8 versus 38.6 years) and basal FSH concentration (8.33 versus 8.65 mIU/mL). No statistically significant differences between the protocol types were noted in peak estradiol levels, amount of gonadotropins used, number of oocytes obtained, or embryos transferred. The pregnancy rates (40% versus 45.2%) and live birth rates (27.7% versus 31.7%) in the GnRH antagonist and flare groups, respectively, were similar.

CONCLUSION(S)

We achieved excellent and comparable pregnancy and live birth rates in poor responders of advanced reproductive age with the use of either GnRH antagonist or flare protocol.

Authors+Show Affiliations

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19131055

Citation

Berin, Inna, et al. "A Comparison of Gonadotropin-releasing Hormone (GnRH) Antagonist and GnRH Agonist Flare Protocols for Poor Responders Undergoing in Vitro Fertilization." Fertility and Sterility, vol. 93, no. 2, 2010, pp. 360-3.
Berin I, Stein DE, Keltz MD. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization. Fertil Steril. 2010;93(2):360-3.
Berin, I., Stein, D. E., & Keltz, M. D. (2010). A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization. Fertility and Sterility, 93(2), 360-3. https://doi.org/10.1016/j.fertnstert.2008.11.007
Berin I, Stein DE, Keltz MD. A Comparison of Gonadotropin-releasing Hormone (GnRH) Antagonist and GnRH Agonist Flare Protocols for Poor Responders Undergoing in Vitro Fertilization. Fertil Steril. 2010;93(2):360-3. PubMed PMID: 19131055.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization. AU - Berin,Inna, AU - Stein,Daniel E, AU - Keltz,Martin D, Y1 - 2009/01/07/ PY - 2008/09/15/received PY - 2008/10/15/revised PY - 2008/11/04/accepted PY - 2009/1/10/entrez PY - 2009/1/10/pubmed PY - 2010/2/25/medline SP - 360 EP - 3 JF - Fertility and sterility JO - Fertil Steril VL - 93 IS - 2 N2 - OBJECTIVE: To compare stimulation profiles, pregnancy, and live birth rates in poor responders during in vitro fertilization (IVF) cycles using either a gonadotropin-releasing hormone (GnRH) antagonist (cetrorelix) or a GnRH agonist flare protocol (leuprolide). DESIGN: Retrospective chart review. SETTING: A university-affiliated IVF program. PATIENT(S): Women designated as poor responders based on a prior stimulation cycle or baseline follicle-stimulating hormone (FSH) level of >10 mIU/mL, who needed at least 375 IU of starting daily gonadotropins in the study cycle. INTERVENTION(S): Administration of GnRH agonist flare or GnRH antagonist protocol. MAIN OUTCOME MEASURE(S): Clinical pregnancy rate, live birth rate. RESULT(S): For 68 GnRH antagonist and 45 GnRH agonist flare cycles, the groups were similar with respect to age (38.8 versus 38.6 years) and basal FSH concentration (8.33 versus 8.65 mIU/mL). No statistically significant differences between the protocol types were noted in peak estradiol levels, amount of gonadotropins used, number of oocytes obtained, or embryos transferred. The pregnancy rates (40% versus 45.2%) and live birth rates (27.7% versus 31.7%) in the GnRH antagonist and flare groups, respectively, were similar. CONCLUSION(S): We achieved excellent and comparable pregnancy and live birth rates in poor responders of advanced reproductive age with the use of either GnRH antagonist or flare protocol. SN - 1556-5653 UR - https://www.unboundmedicine.com/medline/citation/19131055/A_comparison_of_gonadotropin_releasing_hormone__GnRH__antagonist_and_GnRH_agonist_flare_protocols_for_poor_responders_undergoing_in_vitro_fertilization_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(08)04550-0 DB - PRIME DP - Unbound Medicine ER -